2020年全球皮肤黑色素瘤负担及2040年预测
该研究基于GLOBOCAN 2020数据库评估全球侵袭性皮肤黑色素瘤新发与死亡病例。
要点
- 澳大利亚/新西兰发病率最高(男42/10万人年,女31/10万人年),多数非洲和亚洲国家发病率常低于1/10万人年。
核心结论
- 该流行病学评估提示皮肤黑色素瘤仍是全球癌症控制和公共卫生的重要挑战,尤其在欧洲血统的浅肤色人群中。
研究设计与样本
- 基于人群的研究,使用GLOBOCAN 2020数据库对侵袭性黑色素瘤新发病例和死亡进行全球流行病学评估。
- 按国家、世界区域和四层人类发展水平计算每10万人年的年龄标准化发病率和死亡率。
- 计算2040年估计病例数和死亡数。
主要发现
- 澳大利亚/新西兰发病率最高:男性42/10万人年,女性31/10万人年;其次为西欧(男女均19/10万人年)、北美(男18/10万人年,女14/10万人年)、北欧(男17/10万人年,女18/10万人年)。
- 多数非洲和亚洲国家黑色素瘤仍罕见,发病率常低于1/10万人年。
- 死亡率在新西兰最高达5/10万人年,地理差异较发病率小。
- 多数世界区域男性黑色素瘤比女性更常见。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite many cases being preventable, cutaneous melanoma remains the most serious skin cancer worldwide. Understanding the scale and profile of the disease is vital to concentrate and reinforce global prevention efforts. OBJECTIVE: To examine global patterns of cutaneous melanoma in 2020 and to provide projected estimates of cases and deaths by 2040. DESIGN, SETTING, AND PARTICIPANTS: This population-based study used the GLOBOCAN 2020 database for global epidemiological assessment of new cases and deaths due to invasive melanoma. MAIN OUTCOMES AND MEASURES: Age-standardized incidence and mortality rates were calculated per 100 000 person-years by country, world region, and 4-tier level of human development. Estimated numbers of cases and deaths were calculated for the year 2040. RESULTS: A worldwide total of 325 000 new melanoma cases (174 000 males, 151 000 females) and 57 000 deaths (32 000 males, 25 000 females) was estimated for 2020. Large geographic variations existed across countries and world regions, with the highest incidence rates among males (42 per 100 000 person-years) and females (31 per 100 000 person-years) observed in Australia/New Zealand, followed by Western Europe (19 per 100 000 person-years for males and females), North America (18 per 100 000 person-years for males, 14 per 100 000 person-years for females), and Northern Europe (17 per 100 000 person-years for males, 18 per 100 000 person-years for females). Melanoma continued to be rare in most African and Asian countries, with incidence rates commonly less than 1 per 100 000 person-years. Mortality rates peaked at 5 per 100 000 person-years in New Zealand, and geographic variations were less pronounced than for incidence. Melanoma was more frequent among males than females in most world regions. If 2020 rates continue, the burden from melanoma is estimated to increase to 510 000 new cases (a roughly 50% increase) and to 96 000 deaths (a 68% increase) by 2040. CONCLUSIONS AND RELEVANCE: This epidemiological assessment suggests that melanoma remains an important challenge to cancer control and public health globally, especially in fair-skinned populations of European descent.
引用
- Arnold M, Singh D, Laversanne M, et al. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 2022. PMID: 35353115. doi:10.1001/jamadermatol.2022.0160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。